Clinical Trial Update: Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a multi-modality algorithm for non-metastatic pancreatic and ampullary adenocarcinoma was terminated; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Ampulla
• Ductal Adenocarcinoma of Pancreas

Snippet

Sponsor: Essentia Health | Conditions: Ductal Adenocarcinoma of Pancreas, Adenocarcinoma of Ampulla | Phase 2 | Status: TERMINATED | Results posted: 2018-11-13